Kinea Bio, Inc.

About Kinea Bio, Inc.

Kinea Bio is a company focused on accelerating a new era of genetic medicine for neuromuscular diseases. Founded in 2020 by respected scientific leaders in the field, it aims to enable next-generation genetic medicine through bench-to-bedside innovations.

Products & Services

Gene Therapy for Dysferlinopathy:A novel gene therapy targeting Dysferlinopathy, a rare neuromuscular disease, supported by a licensing agreement with Solid Biosciences for capsid technology.

Gene Therapy for DMD (Duchenne Muscular Dystrophy):Lead program featuring a breakthrough gene therapy strategy published in Nature, alongside research on non-viral gene therapy delivery.

Research on DM1 (Myotonic Dystrophy Type 1):Research initiative supported by a Phase 1 NIH Small Business Innovation Research grant.

SIMPLI-GT™ Technology:A groundbreaking technology developed by Kinea's lead scientists for gene therapy applications.

Specialties

Genetic Medicine Gene Therapy Neuromuscular Diseases Duchenne Muscular Dystrophy (DMD) Dysferlinopathy Myotonic Dystrophy (DM1) Non-Viral Gene Therapy Delivery SIMPLI-GT™ Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 500000 MR: - FA: $500,000 FAN: 500000	D: 2024-02-13 FD: 2024-02-13	1 investors

Grant Latest

2024-02-13

$500K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Martin K. (Casey) Childers

Chief Executive Officer

J

Jeffrey Chamberlain

Chief Scientific Advisor

S

Seung Wook Oh, PhD

Chief Operating Officer

M

Michael Cho

Chief Financial Officer, Chief Strategy Officer, and General Counsel

J

Joel Chamberlain

Scientific Advisor

S

Stephen Hauschka, PhD

Scientific Advisor

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Kinea Bio, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised